1α,25-Dihydroxyvitamin D3 inhibits vascular cellular adhesion molecule-1 expression and interleukin-8 production in human coronary arterial endothelial cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 132, Issue 3-5, 2012, Pages 290-294

  Kudo, Keiko ^a   Hasegawa, Shunji ^a   Suzuki, Yasuo ^a   Hirano, Reiji ^a   Wakiguchi, Hiroyuki ^a   Kittaka, Setsuaki ^a   Ichiyama, Takashi ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

1 ,25 Dihydroxyvitamin D3; Coronary arterial endothelial cells; IL 8; Kawasaki disease; VCAM 1

Indexed keywords

ANTIINFLAMMATORY AGENT; CALCITRIOL; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANTIINFLAMMATORY ACTIVITY; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MUCOCUTANEOUS LYMPH NODE SYNDROME; PROTEIN EXPRESSION; VASCULITIS;

CELL ADHESION; CORONARY VESSELS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; INTERLEUKIN-8; MUCOCUTANEOUS LYMPH NODE SYNDROME; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1; VITAMIN D;

EID: 84865551209     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2012.07.003     Document Type: Article

References (46)

1. T. Kawasaki, F. Kosaki, S. Ogawa, I. Shigemitsu, and H. Yanagawa A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan Pediatrics 54 1974 271 276
2. H. Fujiwara, and Y. Hamashima Pathology of the heart in Kawasaki disease Pediatrics 61 1978 100 107
3. H. Kato, T. Sugimura, T. Akagi, N. Sato, K. Hashino, Y. Maeno, T. Kazue, G. Eto, and R. Yamakawa Long-term consequences of Kawasaki disease. A 10-21-year follow-up study of 594 patients Circulation 94 1996 1379 1385
4. S. Furukawa, T. Matsubara, K. Jujoh, K. Yone, T. Sugawara, K. Sasai, H. Kato, and K. Yabuta Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease Clinical Immunology and Immunopathology 48 1988 247 251
5. S. Furukawa, T. Matsubara, K. Yone, Y. Hirano, K. Okumura, and K. Yabuta Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-α and interleukin 6 in serum European Journal of Pediatrics 151 1992 44 47
6. S. Furukawa, T. Matsubara, Y. Umezawa, K. Okumura, and K. Yabuta Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease Journal of Pediatrics 124 1994 721 725
7. T. Ichiyama, T. Yoshitomi, M. Nishikawa, M. Fujiwara, T. Matsubara, T. Hayashi, and S. Furukawa NF-κB activation in peripheral blood monocytes/macrophages and T cells during acute Kawasaki disease Clinical Immunology 99 2001 373 377
8. T. Matsubara, T. Ichiyama, and S. Furukawa Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease Clinical and Experimental Immunology 141 2005 381 387
9. S. Furukawa, K. Imai, T. Matsubara, K. Yone, A. Yachi, K. Okumura, and K. Yabuta Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease Arthritis and Rheumatism 35 1992 672 677
10. D.S. Kim, and K.Y. Lee Serum soluble E-selectin levels in Kawasaki disease Scandinavian Journal of Rheumatology 23 1994 283 286
11. Y.K. Yee, S.R. Chintalacharuvu, J. Lu, S. Nagpal, and Vitamin D receptor modulators for inflammation and cancer Mini Reviews in Medicinal Chemistry 5 2005 761 778
12. 3, and the immune system American Journal of Clinical Nutrition 80 2004 1717S 1720S
13. O. Equils, Y. Naiki, A.M. Shapiro, K. Michelsen, D. Lu, J. Adams, and S. Jordan 1,25-Dihydroxyvitamin D inhibits lipopolysaccharide-induced immune activation in human endothelial cells Clinical and Experimental Immunology 143 2006 58 64
14. 3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation Journal of Immunology 164 2000 2405 2411
15. A. Boonstra, F.J. Barrat, C. Crain, V.L. Heath, H.F. Savelkoul, and A. O'Garra 1α,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells Journal of Immunology 167 2001 4974 4980
16. 3 inhibits IFN-γ and IL-4 levels during in vitro polarization of primary murine CD4+ T cells Journal of Immunology 168 2002 1181 1189
17. 3 in macrophages Journal of Steroid Biochemistry and Molecular Biology 103 2007 558 562
18. 3 inhibits tumor necrosis factor-α-induced adhesion molecule expression in endothelial cells Cell Biology International 30 2006 365 375
19. J.C. Burns, E.V. Capparelli, J.A. Brown, J.W. Newburger, and M.P. Glode Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group Pediatric Infectious Disease Journal 17 1998 1144 1148
20. C.A. Wallace, J.W. French, S.J. Kahn, and D.D. Sherry Initial intravenous gammaglobulin treatment failure in Kawasaki disease Pediatrics 105 2000 E78
21. J.S. Pober, M.A. Gimbrone Jr., L.A. Lapierre, D.L. Mendrick, W. Friers, R. Rothlein, and T.A. Springer Overlapping patterns of activations of human endothelial cells by interleukin-1, tumor necrosis factor, and immune interferon Journal of Immunology 137 1986 1893 1896
22. 3 in human coronary arterial endothelial cells: Implication for the treatment of Kawasaki disease Journal of Steroid Biochemistry and Molecular Biology 113 2009 134 138
23. S.E. Papapoulos, T.L. Clemens, L.M. Sandler, L.J. Fraher, J. Winer, and J.L. O'Riordan The effect of renal function on changes in circulating concentrations of 1,25-dihydroxycholecalciferol after an oral dose Clinical Science 62 1982 427 429
24. B.S. Levine, F.R. Singer, G.F. Bryce, J.P. Mallon, O.N. Miller, and J.W. Coburn Pharmacokinetics and biologic effects of calcitriol in normal humans Journal of Laboratory and Clinical Medicine 105 1985 239 246
25. 3 blocks TNF-induced monocytic tissue factor expression by inhibition of transcription factors AP-1 and NF-κB Laboratory Investigation 87 2007 540 547
26. T.M. Wang, C.J. Chen, T.S. Lee, H.Y. Chao, W.H. Wu, S.C. Hsieh, and A.N. Chiang Docosahexaenoic acid attenuates VCAM-1 expression and NF-κB activation in TNF-α-treated human aortic endothelial cells Journal of Nutritional Biochemistry 22 2011 187 194
27. K.A. Roebuck, and A. Finnegan Regulation of intercellular adhesion molecule-1 (CD54) gene expression Journal of Leukocyte Biology 66 1999 876 888
28. T. Minami, M.R. Abid, J. Zhang, G. King, T. Kodama, and W.C. Aird Thrombin stimulation of vascular adhesion molecule-1 in endothelial cells is mediated by protein kinase C (PKC)-δ-NF-κB and PKC-ζ-GATA signaling pathways Journal of Biological Chemistry 278 2003 6976 6984
29. H. Khalaf, J. Jass, and P.E. Olsson Differential cytokine regulation by NF-κB and AP-1 in Jurkat T-cells BMC Immunology 11 2006 26 38
30. J.E. Do, S.Y. Kwon, S. Park, and E.S. Lee Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behçet's disease Rheumatology 47 2008 840 848
31. M. Stio, M. Martinesi, S. Bruni, C. Treves, C. Mathieu, A. Verstuyf, G. d'Albasio, S. Bagnoli, and A.G. Bonanomi The vitamin D analogue TX 527 blocks NF-κB activation in peripheral blood mononuclear cells of patients with Crohn's disease Journal of Steroid Biochemistry and Molecular Biology 103 2007 51 60
32. M. Martinesi, C. Treves, G. D'Albasio, S. Bagnoli, A.G. Bonanomi, and M. Stio Vitamin D derivatives induce apoptosis and downregulate ICAM-1 levels in peripheral blood mononuclear cells of inflammatory bowel disease patients Inflammatory Bowel Diseases 14 2008 597 604
33. M.T. Cantorna, C. Munsick, C. Bemiss, and B.D. Mahon 1,25- Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease Journal of Nutrition 130 2000 2648 2652
34. J. Smolders, J. Damoiseaux, P. Menheere, R. Hupperts, and Vitamin D as an immune modulator in multiple sclerosis, a review Journal of Neuroimmunology 194 2008 7 17
35. K.L. Munger, S.M. Zhang, E. O'Reilly, E. O'Reilly, M.A. Heranan, M.J. Olek, W.C. Willett, and A. Ascherio Vitamin D intake and incidence of multiple sclerosis Neurology 62 2004 60 65
36. 3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking Journal of Neuroscience Research 85 2007 2480 2490
37. 3 in experimental sepsis International Journal of Medical Sciences 4 2007 190 195
38. S. Patel, T. Farragher, J. Berry, D. Bunn, A. Silman, and D. Symmons Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis Arthritis and Rheumatism 56 2007 2143 2149
39. K. Furusho, T. Kamiya, H. Nakano, N. Kiyosawa, K. Shinomiya, T. Hayashidera, T. Tamura, O. Hirose, Y. Manabe, T. Yokoyama, M. Kawarano, K. Baba, K. Baba, and C. Mori High-dose intravenous gammaglobulin for Kawasaki disease Lancet 2 1984 1055 1058
40. J.W. Newburger, M. Takahashi, J.C. Burns, A.S. Beiser, K.J. Chung, C.E. Duffy, M.P. Glode, W.H. Mason, V. Reddy, S.P. Sanders, S.T. Shulman, J.W. Wiggins, R.V. Hicks, D.R. Fulton, A.B. Lewis, D.Y.M. Leung, T. Colton, F.S. Rosen, and M.E. Melish The treatment of Kawasaki syndrome with intravenous gamma globulin New England Journal of Medicine 315 1986 341 347
41. J.W. Newburger, M. Takahashi, A.S. Beiser, J.C. Burns, J. Bastian, K.J. Chung, S.D. Colan, C.E. Duffy, D.R. Fulton, M.P. Glode, W.H. Mason, H.C. Meissner, A.H. Rowley, S.T. Shulman, V. Reddy, R.P. Sundel, J.W. Wiggins, T. Colton, M.E. Melish, and F.S. Rosen A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome New England Journal of Medicine 324 1991 1633 1639
42. R.C. Dale, M.A. Saleem, S. Daw, and M.J. Dillon Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin Journal of Pediatrics 137 2000 723 726
43. Y. Okada, M. Shinohara, T. Kobayashi, Y. Inoue, T. Tomomasa, T. Kobayashi, A. Morikawa Gunma Kawasaki Disease Study Group Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children Journal of Pediatrics 143 2003 363 367
44. R.P. Sundel, A.L. Baker, D.R. Fulton, and J.W. Newburger Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial Journal of Pediatrics 142 2003 611 616
45. S. Iwashima, M. Seguchi, T. Matubayashi, and T. Ohzeki Ulinastatin therapy in Kawasaki Disease Clinical Drug Investigation 27 2007 691 696
46. J.C. Burns, W.H. Mason, S.B. Hauger, H. Janai, J.F. Bastian, J.D. Wohrley, I. Balfour, C.A. Shen, E.D. Michel, S.T. Shulman, and M.E. Melish Infliximab treatment for refractory Kawasaki syndrome Journal of Pediatrics 146 2005 662 667